Literature DB >> 14738451

Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: an in vitro and in vivo study.

E J Giamarellos-Bourboulis1, D Plachouras, A Tzivra, V Kousoulas, N Bolanos, M Raftogiannis, I Galani, I Dontas, A Dionyssiou-Asteriou, H Giamarellou.   

Abstract

In attempt to investigate the stimulatory effect of Pseudomonas aeruginosa on innate immunity and to correlate it to its level of resistance to antimicrobials, 20 isolates were applied; 8 isolates were susceptible and 12 multidrug-resistant. Genetic diversity was defined by PFGE. Human monocytes of two healthy volunteers were in vitro stimulated by the isolates for the production of pro-inflammatory (TNF-alpha, IL-1beta, IL-6, IL-8 and IL-12) and anti-inflammatory cytokines (IL-10), of malondialdehyde and of procalcitonin. Cytokines were estimated by EIA, malondialdehyde by the thiobarbiturate assay and procalcitonin by an immunochemiluminometric assay. Survival of 48 Wistar rats was recorded after induction of sepsis by the intraperitoneal injection of three susceptible and three multidrug-resistant isolates. To test whether comparative effect of the latter isolates on survival correlates with any difference of monocyte-mediated release of pro-inflammatory mediators, monocytes of two rats were in vitro stimulated for the production of TNF-alpha and of malondialdehyde. In vitro stimulation of human monocytes by the susceptible isolates elicited elevated production of malondiadeheyde, of IL-1beta and of IL-6 compared to stimulation by multidrug-resistant isolates. Similar differences were found for TNF-alpha and IL-8, but they were not statistically significant. Production of IL-10 and IL-12 was not detected after stimulation with any isolate. Levels of procalcitonin were similar after induction with either susceptible or multidrug-resistant isolates. Mean survival of animals was 7.56, 21.80 and 55.20 h, respectively, after challenge by the susceptible isolates and 28.89, 61.8 and more than 120 h, respectively, after challenge by the multidrug-resistant isolates. Differences of survival were accompanied by greater rodent monocyte-release of TNF-alpha and malondialdehyde after stimulation by the susceptible isolates compared to multidrug-resistant ones. It is concluded that considerable differences are encountered on the stimulation of human monocytes by susceptible and resistant isolates of Pseudomonas aeruginosa. These results correlate with in vivo evidence and might influence decision on therapeutics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14738451      PMCID: PMC1808952          DOI: 10.1111/j.1365-2249.2003.02365.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

Review 1.  Cytokines and anticytokines in the pathogenesis of sepsis.

Authors:  T van der Poll; S J van Deventer
Journal:  Infect Dis Clin North Am       Date:  1999-06       Impact factor: 5.982

Review 2.  Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned.

Authors:  K Reinhart; W Karzai
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia.

Authors:  K Kurahashi; O Kajikawa; T Sawa; M Ohara; M A Gropper; D W Frank; T R Martin; J P Wiener-Kronish
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

4.  The effects of infection of thermal injury by Pseudomonas aeruginosa PAO1 on the murine cytokine response.

Authors:  K P Rumbaugh; J A Colmer; J A Griswold; A N Hamood
Journal:  Cytokine       Date:  2001-11-21       Impact factor: 3.861

5.  Plasma redox status relates to severity in critically ill patients.

Authors:  J M Alonso de Vega; J Díaz; E Serrano; L F Carbonell
Journal:  Crit Care Med       Date:  2000-06       Impact factor: 7.598

6.  Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro.

Authors:  M Oberhoffer; I Stonans; S Russwurm; E Stonane; H Vogelsang; U Junker; L Jäger; K Reinhart
Journal:  J Lab Clin Med       Date:  1999-07

7.  Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?

Authors:  Evangelos J Giamarellos-Bourboulis; Anna Mega; Paraskevi Grecka; Nektaria Scarpa; George Koratzanis; George Thomopoulos; Helen Giamarellou
Journal:  Intensive Care Med       Date:  2002-08-07       Impact factor: 17.440

Review 8.  Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology.

Authors:  Evelina Tacconelli; Mario Tumbarello; Silvia Bertagnolio; Rita Citton; Teresa Spanu; Giovanni Fadda; Roberto Cauda
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

9.  Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction.

Authors:  H F Goode; H C Cowley; B E Walker; P D Howdle; N R Webster
Journal:  Crit Care Med       Date:  1995-04       Impact factor: 7.598

10.  Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa.

Authors:  Yoichi Hirakata; Ramakrishnan Srikumar; Keith Poole; Naomasa Gotoh; Takashi Suematsu; Shigeru Kohno; Shimeru Kamihira; Robert E W Hancock; David P Speert
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  13 in total

1.  The myeloid differentiation factor 88 is dispensable for the development of a delayed host response to Pseudomonas aeruginosa lung infection in mice.

Authors:  M R Power; J S Marshall; M Yamamoto; S Akira; T-J Lin
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

2.  Prospective observational study of prior rectal colonization status as a predictor for subsequent development of Pseudomonas aeruginosa clinical infections.

Authors:  Silvia Gómez-Zorrilla; Mariana Camoez; Fe Tubau; Rosario Cañizares; Elisabet Periche; M Angeles Dominguez; Javier Ariza; Carmen Peña
Journal:  Antimicrob Agents Chemother       Date:  2015-06-15       Impact factor: 5.191

3.  Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections.

Authors:  Carmen Peña; Cristina Suarez; Mónica Gozalo; Javier Murillas; Benito Almirante; Virginia Pomar; Manuela Aguilar; Ana Granados; Esther Calbo; Jesús Rodríguez-Baño; Fernando Rodríguez; Fe Tubau; Luis Martínez-Martínez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

4.  Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial.

Authors:  Katerina Kotzampassi; Evagellos J Giamarellos-Bourboulis; Antonios Voudouris; Pantelis Kazamias; Efthimios Eleftheriadis
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

5.  Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.

Authors:  C Peña; S Gómez-Zorrilla; C Suarez; M A Dominguez; F Tubau; O Arch; A Oliver; M Pujol; J Ariza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-04       Impact factor: 3.267

6.  Acute Inflammatory Response of Patients with Pseudomonas aeruginosa Infections: A Prospective Study.

Authors:  Silvia Gómez-Zorrilla; Francisco Morandeira; María José Castro; Fe Tubau; Elisabet Periche; Rosario Cañizares; María Angeles Dominguez; Javier Ariza; Carmen Peña
Journal:  Microb Drug Resist       Date:  2016-10-18       Impact factor: 3.431

7.  Interactions of Klebsiella pneumoniae with the innate immune system vary in relation to clone and resistance phenotype.

Authors:  Iliana-Maria Pantelidou; Irene Galani; Marianna Georgitsi; George L Daikos; Evangelos J Giamarellos-Bourboulis
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

8.  Immunomodulatory intervention in sepsis by multidrug-resistant Pseudomonas aeruginosa with thalidomide: an experimental study.

Authors:  Evangelos J Giamarellos-Bourboulis; Nikolaos Bolanos; George Laoutaris; Vassilios Papadakis; Vassilios Koussoulas; Despina Perrea; Panayotis E Karayannacos; Helen Giamarellou
Journal:  BMC Infect Dis       Date:  2005-06-26       Impact factor: 3.090

9.  Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis.

Authors:  Qianqian Liu; Xiaoqing Li; Wenzhang Li; Xinmiao Du; Jian-Qing He; Chuanmin Tao; Yulin Feng
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379

Review 10.  Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies.

Authors:  Yu Zhang; Xiao-Li Chen; Ai-Wei Huang; Su-Ling Liu; Wei-Jiang Liu; Ni Zhang; Xu-Zai Lu
Journal:  Emerg Microbes Infect       Date:  2016-03-23       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.